Advances in SERDs and Other Novel Endocrine Therapies

H&O  What are the main challenges with endocrine therapy for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer?  KK  The first […]

Alternatives to Intensive Treatment in Patients With AML

Abstract: A significant proportion of patients with acute myeloid leukemia (AML) are unable to tolerate standard induction chemotherapy regimens. This is particularly true for patients who […]